0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous General Anesthetics Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-24V14424
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Intravenous General Anesthetics Market Research Report 2023
BUY CHAPTERS

Global Intravenous General Anesthetics Market Research Report 2025

Code: QYRE-Auto-24V14424
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intravenous General Anesthetics Market Size

The global market for Intravenous General Anesthetics was valued at US$ 5956 million in the year 2024 and is projected to reach a revised size of US$ 7643 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Intravenous General Anesthetics Market

Intravenous General Anesthetics Market

Intravenous anesthesia is administered through a vein to provide general anesthesia.
North American market for Intravenous General Anesthetics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Intravenous General Anesthetics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Intravenous General Anesthetics include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B. Braun Melsungen, Liaoning Haisco, Pfizer, Teva Pharmaceutical Industries, Fresenius Kabi AG, SGPharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous General Anesthetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous General Anesthetics.
The Intravenous General Anesthetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous General Anesthetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous General Anesthetics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous General Anesthetics Market Report

Report Metric Details
Report Name Intravenous General Anesthetics Market
Accounted market size in year US$ 5956 million
Forecasted market size in 2031 US$ 7643 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Sedative
  • Analgesics
  • Muscle Relaxants
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B. Braun Melsungen, Liaoning Haisco, Pfizer, Teva Pharmaceutical Industries, Fresenius Kabi AG, SGPharma, Jiangsu Nhua Pharmaceutical Co., Ltd., Xi'an Libang Pharmaceutical Co., Ltd., Baxter international, Sichuan Guorui Pharmaceutical Co., Ltd., Hikma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intravenous General Anesthetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intravenous General Anesthetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Intravenous General Anesthetics Market growing?

Ans: The Intravenous General Anesthetics Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Intravenous General Anesthetics Market size in 2031?

Ans: The Intravenous General Anesthetics Market size in 2031 will be US$ 7643 million.

Who are the main players in the Intravenous General Anesthetics Market report?

Ans: The main players in the Intravenous General Anesthetics Market are AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B. Braun Melsungen, Liaoning Haisco, Pfizer, Teva Pharmaceutical Industries, Fresenius Kabi AG, SGPharma, Jiangsu Nhua Pharmaceutical Co., Ltd., Xi'an Libang Pharmaceutical Co., Ltd., Baxter international, Sichuan Guorui Pharmaceutical Co., Ltd., Hikma

What are the Application segmentation covered in the Intravenous General Anesthetics Market report?

Ans: The Applications covered in the Intravenous General Anesthetics Market report are Hospital, Clinic

What are the Type segmentation covered in the Intravenous General Anesthetics Market report?

Ans: The Types covered in the Intravenous General Anesthetics Market report are Sedative, Analgesics, Muscle Relaxants

1 Intravenous General Anesthetics Market Overview
1.1 Product Definition
1.2 Intravenous General Anesthetics by Type
1.2.1 Global Intravenous General Anesthetics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sedative
1.2.3 Analgesics
1.2.4 Muscle Relaxants
1.3 Intravenous General Anesthetics by Application
1.3.1 Global Intravenous General Anesthetics Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Intravenous General Anesthetics Market Size Estimates and Forecasts
1.4.1 Global Intravenous General Anesthetics Revenue 2020-2031
1.4.2 Global Intravenous General Anesthetics Sales 2020-2031
1.4.3 Global Intravenous General Anesthetics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Intravenous General Anesthetics Market Competition by Manufacturers
2.1 Global Intravenous General Anesthetics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Intravenous General Anesthetics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Intravenous General Anesthetics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Intravenous General Anesthetics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravenous General Anesthetics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous General Anesthetics, Product Type & Application
2.7 Global Key Manufacturers of Intravenous General Anesthetics, Date of Enter into This Industry
2.8 Global Intravenous General Anesthetics Market Competitive Situation and Trends
2.8.1 Global Intravenous General Anesthetics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intravenous General Anesthetics Players Market Share by Revenue
2.8.3 Global Intravenous General Anesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous General Anesthetics Market Scenario by Region
3.1 Global Intravenous General Anesthetics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Intravenous General Anesthetics Sales by Region: 2020-2031
3.2.1 Global Intravenous General Anesthetics Sales by Region: 2020-2025
3.2.2 Global Intravenous General Anesthetics Sales by Region: 2026-2031
3.3 Global Intravenous General Anesthetics Revenue by Region: 2020-2031
3.3.1 Global Intravenous General Anesthetics Revenue by Region: 2020-2025
3.3.2 Global Intravenous General Anesthetics Revenue by Region: 2026-2031
3.4 North America Intravenous General Anesthetics Market Facts & Figures by Country
3.4.1 North America Intravenous General Anesthetics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Intravenous General Anesthetics Sales by Country (2020-2031)
3.4.3 North America Intravenous General Anesthetics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous General Anesthetics Market Facts & Figures by Country
3.5.1 Europe Intravenous General Anesthetics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Intravenous General Anesthetics Sales by Country (2020-2031)
3.5.3 Europe Intravenous General Anesthetics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous General Anesthetics Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous General Anesthetics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Intravenous General Anesthetics Sales by Region (2020-2031)
3.6.3 Asia Pacific Intravenous General Anesthetics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intravenous General Anesthetics Market Facts & Figures by Country
3.7.1 Latin America Intravenous General Anesthetics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Intravenous General Anesthetics Sales by Country (2020-2031)
3.7.3 Latin America Intravenous General Anesthetics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous General Anesthetics Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous General Anesthetics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Intravenous General Anesthetics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Intravenous General Anesthetics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous General Anesthetics Sales by Type (2020-2031)
4.1.1 Global Intravenous General Anesthetics Sales by Type (2020-2025)
4.1.2 Global Intravenous General Anesthetics Sales by Type (2026-2031)
4.1.3 Global Intravenous General Anesthetics Sales Market Share by Type (2020-2031)
4.2 Global Intravenous General Anesthetics Revenue by Type (2020-2031)
4.2.1 Global Intravenous General Anesthetics Revenue by Type (2020-2025)
4.2.2 Global Intravenous General Anesthetics Revenue by Type (2026-2031)
4.2.3 Global Intravenous General Anesthetics Revenue Market Share by Type (2020-2031)
4.3 Global Intravenous General Anesthetics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Intravenous General Anesthetics Sales by Application (2020-2031)
5.1.1 Global Intravenous General Anesthetics Sales by Application (2020-2025)
5.1.2 Global Intravenous General Anesthetics Sales by Application (2026-2031)
5.1.3 Global Intravenous General Anesthetics Sales Market Share by Application (2020-2031)
5.2 Global Intravenous General Anesthetics Revenue by Application (2020-2031)
5.2.1 Global Intravenous General Anesthetics Revenue by Application (2020-2025)
5.2.2 Global Intravenous General Anesthetics Revenue by Application (2026-2031)
5.2.3 Global Intravenous General Anesthetics Revenue Market Share by Application (2020-2031)
5.3 Global Intravenous General Anesthetics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Intravenous General Anesthetics Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Company Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius-Kabi Intravenous General Anesthetics Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Company Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AbbVie Intravenous General Anesthetics Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Company Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Healthcare Intravenous General Anesthetics Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Company Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 B. Braun Melsungen Intravenous General Anesthetics Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 Liaoning Haisco
6.6.1 Liaoning Haisco Company Information
6.6.2 Liaoning Haisco Description and Business Overview
6.6.3 Liaoning Haisco Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Liaoning Haisco Intravenous General Anesthetics Product Portfolio
6.6.5 Liaoning Haisco Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Intravenous General Anesthetics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Teva Pharmaceutical Industries
6.8.1 Teva Pharmaceutical Industries Company Information
6.8.2 Teva Pharmaceutical Industries Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teva Pharmaceutical Industries Intravenous General Anesthetics Product Portfolio
6.8.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.9 Fresenius Kabi AG
6.9.1 Fresenius Kabi AG Company Information
6.9.2 Fresenius Kabi AG Description and Business Overview
6.9.3 Fresenius Kabi AG Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Fresenius Kabi AG Intravenous General Anesthetics Product Portfolio
6.9.5 Fresenius Kabi AG Recent Developments/Updates
6.10 SGPharma
6.10.1 SGPharma Company Information
6.10.2 SGPharma Description and Business Overview
6.10.3 SGPharma Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SGPharma Intravenous General Anesthetics Product Portfolio
6.10.5 SGPharma Recent Developments/Updates
6.11 Jiangsu Nhua Pharmaceutical Co., Ltd.
6.11.1 Jiangsu Nhua Pharmaceutical Co., Ltd. Company Information
6.11.2 Jiangsu Nhua Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product Portfolio
6.11.5 Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Xi'an Libang Pharmaceutical Co., Ltd.
6.12.1 Xi'an Libang Pharmaceutical Co., Ltd. Company Information
6.12.2 Xi'an Libang Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product Portfolio
6.12.5 Xi'an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Baxter international
6.13.1 Baxter international Company Information
6.13.2 Baxter international Description and Business Overview
6.13.3 Baxter international Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Baxter international Intravenous General Anesthetics Product Portfolio
6.13.5 Baxter international Recent Developments/Updates
6.14 Sichuan Guorui Pharmaceutical Co., Ltd.
6.14.1 Sichuan Guorui Pharmaceutical Co., Ltd. Company Information
6.14.2 Sichuan Guorui Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product Portfolio
6.14.5 Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Hikma
6.15.1 Hikma Company Information
6.15.2 Hikma Description and Business Overview
6.15.3 Hikma Intravenous General Anesthetics Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hikma Intravenous General Anesthetics Product Portfolio
6.15.5 Hikma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous General Anesthetics Industry Chain Analysis
7.2 Intravenous General Anesthetics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous General Anesthetics Production Mode & Process Analysis
7.4 Intravenous General Anesthetics Sales and Marketing
7.4.1 Intravenous General Anesthetics Sales Channels
7.4.2 Intravenous General Anesthetics Distributors
7.5 Intravenous General Anesthetics Customer Analysis
8 Intravenous General Anesthetics Market Dynamics
8.1 Intravenous General Anesthetics Industry Trends
8.2 Intravenous General Anesthetics Market Drivers
8.3 Intravenous General Anesthetics Market Challenges
8.4 Intravenous General Anesthetics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Intravenous General Anesthetics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Intravenous General Anesthetics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Intravenous General Anesthetics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Intravenous General Anesthetics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Intravenous General Anesthetics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Intravenous General Anesthetics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Intravenous General Anesthetics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Intravenous General Anesthetics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Intravenous General Anesthetics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intravenous General Anesthetics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intravenous General Anesthetics, Product Type & Application
 Table 12. Global Key Manufacturers of Intravenous General Anesthetics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous General Anesthetics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous General Anesthetics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous General Anesthetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Intravenous General Anesthetics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Intravenous General Anesthetics Sales Market Share by Region (2020-2025)
 Table 19. Global Intravenous General Anesthetics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Intravenous General Anesthetics Sales Market Share by Region (2026-2031)
 Table 21. Global Intravenous General Anesthetics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Intravenous General Anesthetics Revenue Market Share by Region (2020-2025)
 Table 23. Global Intravenous General Anesthetics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Intravenous General Anesthetics Revenue Market Share by Region (2026-2031)
 Table 25. North America Intravenous General Anesthetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Intravenous General Anesthetics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Intravenous General Anesthetics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Intravenous General Anesthetics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Intravenous General Anesthetics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Intravenous General Anesthetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Intravenous General Anesthetics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Intravenous General Anesthetics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Intravenous General Anesthetics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Intravenous General Anesthetics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Intravenous General Anesthetics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Intravenous General Anesthetics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Intravenous General Anesthetics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Intravenous General Anesthetics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Intravenous General Anesthetics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Intravenous General Anesthetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Intravenous General Anesthetics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Intravenous General Anesthetics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Intravenous General Anesthetics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Intravenous General Anesthetics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Intravenous General Anesthetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Intravenous General Anesthetics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Intravenous General Anesthetics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Intravenous General Anesthetics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Intravenous General Anesthetics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Intravenous General Anesthetics Sales (K Units) by Type (2020-2025)
 Table 51. Global Intravenous General Anesthetics Sales (K Units) by Type (2026-2031)
 Table 52. Global Intravenous General Anesthetics Sales Market Share by Type (2020-2025)
 Table 53. Global Intravenous General Anesthetics Sales Market Share by Type (2026-2031)
 Table 54. Global Intravenous General Anesthetics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Intravenous General Anesthetics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Intravenous General Anesthetics Revenue Market Share by Type (2020-2025)
 Table 57. Global Intravenous General Anesthetics Revenue Market Share by Type (2026-2031)
 Table 58. Global Intravenous General Anesthetics Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Intravenous General Anesthetics Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Intravenous General Anesthetics Sales (K Units) by Application (2020-2025)
 Table 61. Global Intravenous General Anesthetics Sales (K Units) by Application (2026-2031)
 Table 62. Global Intravenous General Anesthetics Sales Market Share by Application (2020-2025)
 Table 63. Global Intravenous General Anesthetics Sales Market Share by Application (2026-2031)
 Table 64. Global Intravenous General Anesthetics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Intravenous General Anesthetics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Intravenous General Anesthetics Revenue Market Share by Application (2020-2025)
 Table 67. Global Intravenous General Anesthetics Revenue Market Share by Application (2026-2031)
 Table 68. Global Intravenous General Anesthetics Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Intravenous General Anesthetics Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Intravenous General Anesthetics Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Fresenius-Kabi Company Information
 Table 76. Fresenius-Kabi Description and Business Overview
 Table 77. Fresenius-Kabi Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Fresenius-Kabi Intravenous General Anesthetics Product
 Table 79. Fresenius-Kabi Recent Developments/Updates
 Table 80. AbbVie Company Information
 Table 81. AbbVie Description and Business Overview
 Table 82. AbbVie Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AbbVie Intravenous General Anesthetics Product
 Table 84. AbbVie Recent Developments/Updates
 Table 85. Baxter Healthcare Company Information
 Table 86. Baxter Healthcare Description and Business Overview
 Table 87. Baxter Healthcare Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Baxter Healthcare Intravenous General Anesthetics Product
 Table 89. Baxter Healthcare Recent Developments/Updates
 Table 90. B. Braun Melsungen Company Information
 Table 91. B. Braun Melsungen Description and Business Overview
 Table 92. B. Braun Melsungen Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. B. Braun Melsungen Intravenous General Anesthetics Product
 Table 94. B. Braun Melsungen Recent Developments/Updates
 Table 95. Liaoning Haisco Company Information
 Table 96. Liaoning Haisco Description and Business Overview
 Table 97. Liaoning Haisco Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Liaoning Haisco Intravenous General Anesthetics Product
 Table 99. Liaoning Haisco Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer Intravenous General Anesthetics Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Teva Pharmaceutical Industries Company Information
 Table 106. Teva Pharmaceutical Industries Description and Business Overview
 Table 107. Teva Pharmaceutical Industries Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Teva Pharmaceutical Industries Intravenous General Anesthetics Product
 Table 109. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 110. Fresenius Kabi AG Company Information
 Table 111. Fresenius Kabi AG Description and Business Overview
 Table 112. Fresenius Kabi AG Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Fresenius Kabi AG Intravenous General Anesthetics Product
 Table 114. Fresenius Kabi AG Recent Developments/Updates
 Table 115. SGPharma Company Information
 Table 116. SGPharma Description and Business Overview
 Table 117. SGPharma Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. SGPharma Intravenous General Anesthetics Product
 Table 119. SGPharma Recent Developments/Updates
 Table 120. Jiangsu Nhua Pharmaceutical Co., Ltd. Company Information
 Table 121. Jiangsu Nhua Pharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Jiangsu Nhua Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product
 Table 124. Jiangsu Nhua Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Xi'an Libang Pharmaceutical Co., Ltd. Company Information
 Table 126. Xi'an Libang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Xi'an Libang Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product
 Table 129. Xi'an Libang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Baxter international Company Information
 Table 131. Baxter international Description and Business Overview
 Table 132. Baxter international Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Baxter international Intravenous General Anesthetics Product
 Table 134. Baxter international Recent Developments/Updates
 Table 135. Sichuan Guorui Pharmaceutical Co., Ltd. Company Information
 Table 136. Sichuan Guorui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sichuan Guorui Pharmaceutical Co., Ltd. Intravenous General Anesthetics Product
 Table 139. Sichuan Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Hikma Company Information
 Table 141. Hikma Description and Business Overview
 Table 142. Hikma Intravenous General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Hikma Intravenous General Anesthetics Product
 Table 144. Hikma Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Intravenous General Anesthetics Distributors List
 Table 148. Intravenous General Anesthetics Customers List
 Table 149. Intravenous General Anesthetics Market Trends
 Table 150. Intravenous General Anesthetics Market Drivers
 Table 151. Intravenous General Anesthetics Market Challenges
 Table 152. Intravenous General Anesthetics Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous General Anesthetics
 Figure 2. Global Intravenous General Anesthetics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Intravenous General Anesthetics Market Share by Type: 2024 & 2031
 Figure 4. Sedative Product Picture
 Figure 5. Analgesics Product Picture
 Figure 6. Muscle Relaxants Product Picture
 Figure 7. Global Intravenous General Anesthetics Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Intravenous General Anesthetics Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global Intravenous General Anesthetics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Intravenous General Anesthetics Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Intravenous General Anesthetics Sales (2020-2031) & (K Units)
 Figure 14. Global Intravenous General Anesthetics Average Price (US$/Unit) & (2020-2031)
 Figure 15. Intravenous General Anesthetics Report Years Considered
 Figure 16. Intravenous General Anesthetics Sales Share by Manufacturers in 2024
 Figure 17. Global Intravenous General Anesthetics Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Intravenous General Anesthetics Players: Market Share by Revenue in Intravenous General Anesthetics in 2024
 Figure 19. Intravenous General Anesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Intravenous General Anesthetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Intravenous General Anesthetics Sales Market Share by Country (2020-2031)
 Figure 22. North America Intravenous General Anesthetics Revenue Market Share by Country (2020-2031)
 Figure 23. United States Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Intravenous General Anesthetics Sales Market Share by Country (2020-2031)
 Figure 26. Europe Intravenous General Anesthetics Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Intravenous General Anesthetics Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Intravenous General Anesthetics Revenue Market Share by Region (2020-2031)
 Figure 34. China Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Intravenous General Anesthetics Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Intravenous General Anesthetics Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Intravenous General Anesthetics Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Intravenous General Anesthetics Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Intravenous General Anesthetics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Intravenous General Anesthetics by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Intravenous General Anesthetics by Type (2020-2031)
 Figure 53. Global Intravenous General Anesthetics Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Intravenous General Anesthetics by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Intravenous General Anesthetics by Application (2020-2031)
 Figure 56. Global Intravenous General Anesthetics Price (US$/Unit) by Application (2020-2031)
 Figure 57. Intravenous General Anesthetics Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart